NEW HAVEN, Conn. — August 11, 2025 — Leads & Copy — BioXcel Therapeutics, Inc. (Nasdaq: BTAI) CEO Vimal Mehta, Ph.D., will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference in Boston on Tuesday, Aug. 12, 2025, at 12 p.m. ET, the company announced today.
A webcast of the fireside chat can be accessed on the Events & Presentations page under the “News/Events” tab in the Investors & Media section of the company’s website at bioxceltherapeutics.com. A replay will be available for 90 days.
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. Its wholly owned subsidiary, OnkosXcel Therapeutics, is focused on the development of medicines in immuno-oncology.
Contact:
David Schull, Russo Partners, 1.858.717.2310
Source: BioXcel Therapeutics, Inc.
